CRX rs121912653: Understanding This Rare Genetic Variant
The rs121912653 variant is a rare genetic change located within the CRX gene, which provides instructions for proteins essential to eye health. This specific variant is associated with inherited retinal disorders, including cone-rod dystrophy and Leber congenital amaurosis.
What each genotype means
Typical retinal gene function
This genotype represents the common, non-pathogenic sequence for this location in the CRX gene. Individuals with this profile do not carry the specific mutation associated with the described autosomal dominant cone-rod dystrophy or Leber congenital amaurosis.
This is the most common genotype found in the general population globally.
Pathogenic retinal variant carrier
This genotype indicates the presence of a pathogenic mutation in one copy of the CRX gene. Research associates this variant with autosomal dominant cone-rod dystrophy and Leber congenital amaurosis, which are characterized by progressive photoreceptor degeneration and vision loss. Because this is a rare and clinically significant finding, individuals should consult with a medical geneticist or ophthalmologist for clinical evaluation.
This specific genotype is extremely rare globally.
Pathogenic retinal variant homozygous
This genotype indicates the presence of the pathogenic mutation in both copies of the CRX gene. Such variants are associated with severe inherited retinal degeneration, including Leber congenital amaurosis. Clinical correlation with a specialist is essential to understand the implications for retinal health and vision.
This genotype is exceptionally rare and is not typically observed in the general population.
What is the rs121912653 Variant?
The rs121912653 variant is a specific alteration in the DNA sequence of the CRX gene. In genetics, a variant represents a difference in the genetic code compared to the most common sequence found in the general population. This particular variant is categorized as a pathogenic mutation, meaning it is known to disrupt the normal function of the gene. It is located on chromosome 19, specifically within the homeodomain region of the CRX protein. This region is critical because it allows the protein to bind to DNA and regulate the activity of other genes. When a variant occurs in this functional area, it can interfere with the protein's ability to perform its job, which is essential for the development and maintenance of specialized light-sensing cells in the retina.
The Role of the CRX Gene
The CRX gene, which stands for cone-rod homeobox, plays a vital role in the development and survival of photoreceptor cells in the retina. These cells, known as rods and cones, are responsible for converting light into electrical signals that the brain interprets as vision. Cones are primarily responsible for color vision and visual acuity in bright light, while rods are essential for vision in low-light conditions. The protein produced by the CRX gene acts as a transcription factor, a type of protein that turns other genes on or off. By regulating this complex network of genes, CRX ensures that photoreceptor cells mature correctly and remain healthy throughout a person's life. When the CRX gene is mutated, the resulting protein may be non-functional or behave in a way that harms the cell, leading to the gradual deterioration of these critical light-sensing cells.
Research and Clinical Associations
Scientific research has linked mutations in the CRX gene, including rs121912653, to several inherited retinal dystrophies. These conditions include cone-rod dystrophy and Leber congenital amaurosis. Cone-rod dystrophy is characterized by a progressive loss of visual sharpness, increased sensitivity to light, and impaired color vision. Leber congenital amaurosis is a more severe condition that typically causes significant vision loss from infancy. The evidence for these associations is grounded in clinical studies where individuals presenting with these symptoms were found to carry pathogenic variants in the CRX gene. It is important to note that while these associations are well-documented in clinical literature, the specific impact of a variant can vary between individuals. Genetic research is ongoing to understand why the same gene mutation can sometimes lead to different clinical outcomes or varying degrees of severity in different patients.
What You Can Do With This Information
If you or a family member have been identified as a carrier of the rs121912653 variant, it is essential to consult with a healthcare professional, such as a genetic counselor or an ophthalmologist specializing in retinal diseases. This information is not a diagnosis, and the presence of a variant does not automatically guarantee the development of a specific condition. Genetic testing results should always be interpreted in the context of a person's clinical history and physical examination. A medical professional can help explain what these findings mean for your health or the health of your family members. They can also provide guidance on appropriate monitoring, potential clinical trials, or supportive care options. Avoid making medical decisions based solely on genetic reports; always rely on the expertise of clinicians who can integrate your genetic data with your overall health profile.
How common is this variant?
The rs121912653 variant is extremely rare in the global population, appearing at a very low frequency in large-scale genomic databases.
Frequently asked questions
Is rs121912653 a common genetic variant?
No, rs121912653 is considered extremely rare. It is not a common variant found in the general population.
What conditions are linked to CRX mutations?
Mutations in the CRX gene are associated with inherited retinal diseases, most notably cone-rod dystrophy and Leber congenital amaurosis. These conditions involve the progressive loss of photoreceptor cells in the eye.
Does having this variant mean I will lose my vision?
Not necessarily. While this variant is associated with retinal conditions, genetic testing results must be interpreted by a medical professional who can assess your specific clinical situation and family history.
Where can I find more information about my genetic results?
You should discuss your genetic report with a genetic counselor or an ophthalmologist. They are trained to explain the clinical significance of specific variants and how they relate to your health.
Sources & further reading
Educational information only, last refreshed 10/10/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs121912653?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in CRX
A dominant missense variant in the CRX homeobox transcription factor causing Leber congenital amaurosis and cone-rod dystrophy.
A missense variant in the CRX homeodomain disrupting retinal photoreceptor cell differentiation and survival.
This variant in the cone-rod homeobox transcription factor gene causes autosomal dominant cone-rod dystrophy and Leber congenital amaurosis.
Pathogenic missense variant in the CRX homeodomain associated with autosomal dominant cone-rod dystrophy and severe visual impairment.
Encodes the Glu80Ala missense change in the cone-rod homeobox factor, causing autosomal dominant cone-rod dystrophy and severe visual acuity decline.
This pathogenic variant in the CRX gene is linked to Retinitis pigmentosa, affecting retinal photoreceptor development.